Insights On Upstream Manufacturing

  1. Accelerating CHO Media Development: From Screening To AI Design 10/1/2026

    Discover how high-throughput screening, process analytics, and AI-guided modeling can help identify promising CHO media and feed combinations faster and support a more predictive approach.

  2. Evaluating Modular CAR T Manufacturing Workflows 9/28/2026

    As CAR T manufacturing scales, balancing throughput, flexibility, and cell quality becomes increasingly complex. Explore strategies for improving process control, reducing bottlenecks, and more.

  3. Enabling Closed-System Bioprocessing With Single-Use Technologies 9/28/2026

    Learn how custom single-use solutions create closed fluid pathways across upstream and downstream operations, helping manufacturers strengthen sterility assurance and simplify scale-up.

  4. Biotech's Dirty Little Secret: The Hidden Cost Of Manual Roller Bottles 9/27/2026

    Roller bottles are essential for adherent cell culture, but manual handling can limit efficiency. Explore automation and closed systems to improve scalability, sterility, and compliance.

  5. Resolving In-Vitro Diagnostic Supply Chain Constraints 9/27/2026

    Explore strategies for securing recombinant proteins while addressing supply continuity, batch consistency, scale-up challenges, and quality requirements for clinical validation and commercialization.

  6. Transgenic Fruit Flies vs. Cell Lines: Eliminating Bioreactor Bottlenecks 9/26/2026

    Overcome biomanufacturing tradeoffs with expression strategies that enhance stability, scalability, and production consistency.

  7. Beyond The Bioreactor Scaling CGT Ancillary Materials With The EntoEngineā„¢ 9/26/2026

    Growing demand for cell and gene therapies is increasing pressure on cytokine production. Explore interleukin manufacturing, quality, consistency, safety, scalability, and supply reliability.

  8. From Sequence To Scale In Seven Months 9/26/2026

    Accelerate recombinant protein development from sequence to scale while maintaining stable expression, manufacturing efficiency, and critical quality attributes.

  9. Manufacturing Glycosylated Erythropoietin Without š¯›¼1,3-Fucosylation 9/26/2026

    See how expression hosts affect recombinant EPO glycosylation, bioactivity, and consistency, with reproducible N-glycan profiles and absence of α1,3-linked fucosylation.

  10. Characterization Of Fly-Derived Prolactin: Insights Into Glycosylation And Activity 9/26/2026

    Explore how D. mel-derived human prolactin (hPRL) compares with hPRL expressed in E. coli and HEK293 cells through detailed physico-chemical and biological characterization.